Annual Cash & Cash Equivalents
$2.40 M
-$459.40 K-16.06%
December 31, 2023
Summary
- As of February 7, 2025, QNRX annual cash & cash equivalents is $2.40 million, with the most recent change of -$459.40 thousand (-16.06%) on December 31, 2023.
- During the last 3 years, QNRX annual cash & cash equivalents has risen by +$2.08 million (+641.57%).
- QNRX annual cash & cash equivalents is now -67.91% below its all-time high of $7.48 million, reached on December 31, 2021.
Performance
QNRX Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$3.12 M
+$271.70 K+9.55%
September 30, 2024
Summary
- As of February 7, 2025, QNRX quarterly cash and cash equivalents is $3.12 million, with the most recent change of +$271.70 thousand (+9.55%) on September 30, 2024.
- Over the past year, QNRX quarterly cash and cash equivalents has increased by +$1.28 million (+69.99%).
- QNRX quarterly cash and cash equivalents is now -58.35% below its all-time high of $7.48 million, reached on December 1, 2021.
Performance
QNRX Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
QNRX Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -16.1% | +70.0% |
| 3 y3 years | +641.6% | -7.6% |
| 5 y5 years | - | -7.6% |
QNRX Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -67.9% | at low | -58.4% | +70.0% |
| 5 y | 5-year | -67.9% | +641.6% | -58.4% | +862.6% |
| alltime | all time | -67.9% | +641.6% | -58.4% | +862.6% |
Quoin Pharmaceuticals Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $3.12 M(+9.5%) |
| Jun 2024 | - | $2.85 M(+55.2%) |
| Mar 2024 | - | $1.83 M(-23.6%) |
| Dec 2023 | $2.40 M(-16.1%) | $2.40 M(-24.1%) |
| Sep 2023 | - | $3.16 M(-33.5%) |
| Jun 2023 | - | $4.76 M(+41.1%) |
| Mar 2023 | - | $3.37 M(+17.9%) |
| Dec 2022 | $2.86 M | $2.86 M(-45.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $5.25 M(+95.3%) |
| Jun 2022 | - | $2.69 M(-48.2%) |
| Mar 2022 | - | $5.19 M(-30.7%) |
| Dec 2021 | $7.48 M(+2210.9%) | - |
| Dec 2021 | - | $7.48 M(+1046.3%) |
| Sep 2021 | - | $652.80 K(-62.1%) |
| Jun 2021 | - | $1.72 M(+431.4%) |
| Dec 2020 | $323.80 K | - |
| Dec 2020 | - | $323.80 K |
FAQ
- What is Quoin Pharmaceuticals annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Quoin Pharmaceuticals?
- What is Quoin Pharmaceuticals annual cash & cash equivalents year-on-year change?
- What is Quoin Pharmaceuticals quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Quoin Pharmaceuticals?
- What is Quoin Pharmaceuticals quarterly cash and cash equivalents year-on-year change?
What is Quoin Pharmaceuticals annual cash & cash equivalents?
The current annual cash & cash equivalents of QNRX is $2.40 M
What is the all time high annual cash & cash equivalents for Quoin Pharmaceuticals?
Quoin Pharmaceuticals all-time high annual cash & cash equivalents is $7.48 M
What is Quoin Pharmaceuticals annual cash & cash equivalents year-on-year change?
Over the past year, QNRX annual cash & cash equivalents has changed by -$459.40 K (-16.06%)
What is Quoin Pharmaceuticals quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of QNRX is $3.12 M
What is the all time high quarterly cash and cash equivalents for Quoin Pharmaceuticals?
Quoin Pharmaceuticals all-time high quarterly cash and cash equivalents is $7.48 M
What is Quoin Pharmaceuticals quarterly cash and cash equivalents year-on-year change?
Over the past year, QNRX quarterly cash and cash equivalents has changed by +$1.28 M (+69.99%)